{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:45:20Z","timestamp":1777013120889,"version":"3.51.4"},"reference-count":93,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Angiosarcomas are extremely aggressive malignant tumors that arise from vascular endothelial cells. The risk factors, etiology, prognostic factors, and optimal management strategies for angiosarcomas are as yet unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively analyzed data from 15 patients who were treated in Asan Medical Center, Seoul, Republic of Korea, in the past 12 years, to assess the effect of different treatment modalities and reconstructive methods on the locoregional recurrence, metastasis, and overall survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 15 patients were identified (median age at diagnosis, 72 years; range, 61\u201382 years). Median tumor size was 6 cm. Median follow-up was 287 days. The median overall survival was 14.96 months; a total of 13 (87%) patients had died by the end of the study.<\/jats:p>\n            <jats:p>The median locoregional recurrence, metastasis, and overall survival were 7.3, 6.5, and 16.7 months, respectively. On univariate analysis, the use of adjuvant therapy after surgery (vs surgery without adjuvant therapy) was associated with delayed median time to detection of recurrence (7.9 months vs 3.1 months, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.825), delayed median time to metastasis (8.7 months vs 3.1 months, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.191), and better median overall survival (7.3 months vs 3.1 months, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.078).<\/jats:p>\n            <jats:p>The use of flap versus skin graft as a reconstructive method was associated with delayed median recurrence (8.75 vs 7.32 months, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.274) and earlier median metastasis (3.75 vs 6.53 months, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.365), but the same median overall survival of 16.7 months (<jats:italic toggle=\"yes\">P<\/jats:italic> value: 0.945) and tumor smaller or bigger than 5 cm show earlier median time to detection of recurrence (4.17-7.32 months; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.41), earlier median time to metastasis (3.75-6.53 months; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.651), but better median overall survival of 18.21 versus 16.7 months, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.111).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Multimodal treatment that combines surgery with adjuvant therapy is the best management strategy that influences survival positively in patients with angiosarcoma. The study shows that the reconstructive method does not affect the prognosis in these patients. So it is better to choose the simplest suitable resection and reconstructive method with the least complications and to avoid unnecessary procedures.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000001865","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T08:59:04Z","timestamp":1560416344000},"page":"55-62","source":"Crossref","is-referenced-by-count":9,"title":["The Management and Prognosis of Facial and Scalp Angiosarcoma"],"prefix":"10.1097","volume":"83","author":[{"given":"Nedhal A.","family":"Alqumber","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery, Prince Sultan Military Medical City, Riyadh, Saudi Arabia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Woo","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, University of Ulsan College of Medicine, Seoul Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-kyu","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, University of Ulsan College of Medicine, Seoul Asan Medical Center, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230923","first-page":"158","article-title":"Soft tissue sarcoma clinical practice guidelines in oncology","volume":"3","year":"2005","journal-title":"J Natl Compr Cancer Netw"},{"key":"bib2-20230923","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0190-9622(98)70237-3","article-title":"Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms","volume":"38","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"bib3-20230923","first-page":"1317","article-title":"Angiosarcoma, classification, histological differentiation","volume":"4","year":"2017","journal-title":"Review"},{"key":"bib4-20230923","first-page":"31","article-title":"Histological differentiation, histogenesis and prognosis of cutaneous angiosarcoma","volume":"57","year":"2011","journal-title":"Osaka City Med J"},{"key":"bib5-20230923","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases","volume":"119","year":"2006","journal-title":"Int J Cancer"},{"key":"bib6-20230923","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","article-title":"Angiosarcoma","volume":"11","year":"2010","journal-title":"Lancet Oncol"},{"key":"bib7-20230923","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/000348949710601110","article-title":"Angiosarcomas of the head and neck: clinical and pathologic characteristics","volume":"106","year":"1997","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"bib8-20230923","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1259\/bjr\/31655219","article-title":"Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients","volume":"85","year":"2012","journal-title":"Br J Radiol"},{"key":"bib9-20230923","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoto.2014.3584","article-title":"Angiosarcoma of the scalp and face: the Mayo Clinic experience","volume":"141","year":"2015","journal-title":"JAMA Otolaryngol - Head Neck Surg"},{"key":"bib10-20230923","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1200\/JCO.2009.25.1728","article-title":"Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?","volume":"28","year":"2010","journal-title":"J Clin Oncol"},{"key":"bib11-20230923","first-page":"504","article-title":"The epidemiology of soft tissue sarcoma","volume":"24","year":"1997","journal-title":"Semin Oncol"},{"key":"bib12-20230923","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/cncr.11667","article-title":"Cutaneous angiosarcoma of the scalp: a multidisciplinary approach","volume":"98","year":"2003","journal-title":"Cancer"},{"key":"bib13-20230923","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PAS.0b013e3180f633a3","article-title":"Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases","volume":"32","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"bib14-20230923","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00000478-199806000-00005","article-title":"Angiosarcoma of soft tissue: a study of 80 cases","volume":"22","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"bib15-20230923","first-page":"1507","article-title":"Angiosarcoma of the of scalp with calvarium involvement in a 50-year-old African-American man","year":"2004","journal-title":"J Natl Med Assoc"},{"key":"bib16-20230923","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/1097-0142(197909)44:3<1106::AID-CNCR2820440345>3.0.CO;2-C","article-title":"Cutaneous angiosarcoma of the head and neck","volume":"44","year":"1979","journal-title":"Cancer"},{"key":"bib17-20230923","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4103\/ijmpo.ijmpo_81_16","article-title":"A novel presentation of cutaneous angiosarcoma: a case report and review","volume":"38","year":"2017","journal-title":"Indian J Med Paediatr Oncol"},{"key":"bib18-20230923","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jclinpath-2017-204601","article-title":"Cutaneous angiosarcoma: a current update","volume":"70","year":"2017","journal-title":"J Clin Pathol"},{"key":"bib19-20230923","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4103\/idoj.IDOJ_379_16","article-title":"Cutaneous angiosarcoma of scalp","volume":"8","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"bib20-20230923","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fonc.2018.00046","article-title":"Cutaneous angiosarcoma: the possibility of new treatment options especially for patients with large primary tumor","volume":"8","year":"2018","journal-title":"Front Oncol"},{"key":"bib21-20230923","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40425-017-0263-0","article-title":"Angiosarcoma treated successfully with anti-PD-1 therapy\u2014a case report","volume":"5","year":"2017","journal-title":"J Immunother Cancer"},{"key":"bib22-20230923","first-page":"360","article-title":"Positive PD-L1 expression predicts worse outcome in cutaneous angiosarcoma","volume":"3","year":"2016","journal-title":"J Glob Oncol"},{"key":"bib23-20230923","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4149\/neo_2017_615","article-title":"Expression of thymidylate synthase (TS) and its prognostic significance in patients with cutaneous angiosarcoma","volume":"64","year":"2017","journal-title":"Neoplasma"},{"key":"bib24-20230923","first-page":"798403","article-title":"Sporadic versus radiation-associated angiosarcoma: a comparative clinicopathologic and molecular analysis of 48 cases","volume":"2013","year":"2013","journal-title":"Sarcoma"},{"key":"bib25-20230923","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/PAS.0b013e318176dbc7","article-title":"Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic","volume":"32","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"bib26-20230923","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1245\/s10434-013-3083-6","article-title":"Cutaneous angiosarcoma: a single-institution experience","volume":"20","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"bib27-20230923","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(74)90683-7","article-title":"Angiosarcoma of the liver in a vinyl-chloride worker","volume":"303","year":"1974","journal-title":"Lancet"},{"key":"bib30-20230923","first-page":"1248","article-title":"Holland R, Acevedo AR. Carcinogen AASA","year":"1965","journal-title":"Current status of arsenic"},{"issue":"suppl 5","key":"bib31-20230923","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1289\/ehp.02110s5883","article-title":"Pathology related to chronic arsenic exposure","volume":"110","year":"2002","journal-title":"Environ Health Perspect"},{"key":"bib32-20230923","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1046\/j.1523-1747.2000.00005-3.x","article-title":"VEGF and its receptors are expressed in a pediatric angiosarcoma in a patient with Aicardi's syndrome","volume":"114","year":"2000","journal-title":"J Invest Dermatol"},{"key":"bib33-20230923","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jaad.2013.03.011","article-title":"Angiosarcoma in patients with xeroderma pigmentosum: less aggressive and not so rare?","volume":"69","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"bib34-20230923","first-page":"185323","article-title":"Angiosarcoma arising in a patient with a 10-year-old hemangioma","volume":"2014","year":"2014","journal-title":"Case Rep Oncol Med"},{"key":"bib35-20230923","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/pbc.25067","article-title":"Malignant transformation of infantile hemangioma to angiosarcoma: response to chemotherapy with bevacizumab","volume":"61","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"bib36-20230923","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1477-7819-7-99","article-title":"Atypical presentation of angiosarcoma of the scalp in the setting of human immunodeficiency virus (HIV)","volume":"7","year":"2009","journal-title":"World J Surg Oncol"},{"key":"bib37-20230923","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/00015458.2014.11680982","article-title":"Angiosarcoma arising in an arteriovenous fistula in a patient without kidney transplant","volume":"114","year":"2014","journal-title":"Acta Chir Belg"},{"key":"bib38-20230923","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/1097-0142(19881201)62:11<2436::AID-CNCR2820621132>3.0.CO;2-J","article-title":"Angiosarcoma associated with foreign body material. A report of three cases","volume":"62","year":"1988","journal-title":"Cancer"},{"key":"bib39-20230923","first-page":"2014","article-title":"Neuro-oncology","year":"2014","journal-title":"Dent Abstr"},{"key":"bib40-20230923","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0301-0503(77)80098-2","article-title":"Haemangiosarcoma following irradiation of a haemangioma of the face. (case report)","volume":"5","year":"1977","journal-title":"J Maxillofac Surg"},{"key":"bib41-20230923","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jgo.2014.02.004","article-title":"Angiosarcoma of the face and scalp: effective systemic treatment in the older patient","volume":"5","year":"2014","journal-title":"J Geriatr Oncol"},{"key":"bib42-20230923","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/1097-0142(19811015)48:8<1907::AID-CNCR2820480832>3.0.CO;2-T","article-title":"Angiosarcoma of skin and soft tissue: a study of forty-four cases","volume":"48","year":"1981","journal-title":"Cancer"},{"key":"bib43-20230923","first-page":"73","article-title":"Diagnostic dilemma; report of a bizarre case of advanced scalp and face angiosarcoma and literature review","volume":"4","year":"2011","journal-title":"Int Med Case Rep J"},{"key":"bib44-20230923","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anndiagpath.2010.07.012","article-title":"Cutaneous angiosarcoma. Analysis of 434 cases from the surveillance, epidemiology, and end results program, 1973-2007","volume":"15","year":"2011","journal-title":"Ann Diagn Pathol"},{"key":"bib45-20230923","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hed.21513","article-title":"Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp","volume":"33","year":"2011","journal-title":"Head Neck"},{"key":"bib46-20230923","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/cup.12166","article-title":"Pseudolymphomatous cutaneous angiosarcoma: a report of 2 new cases arising in an unusual setting","volume":"40","year":"2013","journal-title":"J Cutan Pathol"},{"key":"bib47-20230923","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/ijc.28581","article-title":"CD8+tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma","volume":"134","year":"2014","journal-title":"Int J Cancer"},{"key":"bib48-20230923","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0035-1547520","article-title":"Angiosarcoma of the head and neck","volume":"19","year":"2015","journal-title":"Int Arch Otorhinolaryngol"},{"key":"bib49-20230923","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jclinpath-2014-202629","article-title":"The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases","volume":"68","year":"2015","journal-title":"J Clin Pathol"},{"key":"bib50-20230923","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2011.420","article-title":"Platelet endothelial cell adhesion molecule-1 (PECAM-1\/CD31) and CD99 are critical in lymphatic transmigration of human dendritic cells","volume":"132","year":"2012","journal-title":"J Invest Dermatol"},{"key":"bib51-20230923","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tem.2007.03.002","article-title":"ETS transcription factors in endocrine systems","volume":"18","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"bib52-20230923","first-page":"259","article-title":"The role of ETS transcription factors in mediating cellular","year":"2004","journal-title":"Transformation"},{"key":"bib53-20230923","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/j.jdermsci.2017.02.070","article-title":"Analysis of oncostatin M signaling in hemangiosarcoma cell line and regulation of IL-33 expression","volume":"86","year":"2017","journal-title":"J Dermatol Sci"},{"key":"bib54-20230923","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/modpathol.2013.161","article-title":"ERG and FLI1 protein expression in epithelioid sarcoma","volume":"27","year":"2014","journal-title":"Mod Pathol"},{"key":"bib55-20230923","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00000478-200108000-00011","article-title":"Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics","volume":"25","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"bib56-20230923","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.3800065","article-title":"Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody","volume":"17","year":"2004","journal-title":"Mod Pathol"},{"key":"bib57-20230923","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2559.2012.04286.x","article-title":"Expression of ERG, an Ets family transcription factor, distinguishes cutaneous angiosarcoma from histological mimics","volume":"61","year":"2012","journal-title":"Histopathology"},{"key":"bib58-20230923","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/modpathol.3880543","article-title":"Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas","volume":"15","year":"2002","journal-title":"Mod Pathol"},{"key":"bib59-20230923","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5858\/arpa.2011-0213-OA","article-title":"Utility of immunohistochemical staining with FLI1, D2-40, CD31, and CD34 in the diagnosis of acquired immunodeficiency syndrome-related and non-acquired immunodeficiency syndrome-related kaposi sarcoma","volume":"136","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"bib60-20230923","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4149\/neo_2017_216","article-title":"Prognostic impact of LAT1 and CD98 expression in cutaneous angiosarcoma","volume":"64","year":"2017","journal-title":"Neoplasma"},{"key":"bib61-20230923","doi-asserted-by":"crossref","first-page":"36041","DOI":"10.18632\/oncotarget.5936","article-title":"Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway","volume":"6","year":"2015","journal-title":"Oncotarget"},{"key":"bib62-20230923","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/bjc.2014.359","article-title":"Key roles for MYC, KIT and RET signaling in secondary angiosarcomas","volume":"111","year":"2014","journal-title":"Br J Cancer"},{"key":"bib63-20230923","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/0008-5472.CAN-09-2068","article-title":"KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors","volume":"69","year":"2009","journal-title":"Cancer Res"},{"key":"bib64-20230923","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/2229-516X.165382","article-title":"Tolerance of skin grafts to postoperative radiotherapy","volume":"5","year":"2015","journal-title":"Int J Appl Basic Med Res"},{"key":"bib65-20230923","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.sap.0000123353.71205.43","article-title":"Outcome of split-thickness skin grafts after external beam radiotherapy","volume":"52","year":"2004","journal-title":"Ann Plast Surg"},{"key":"bib66-20230923","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0360-3016(03)00200-1","article-title":"Tolerance of tissue transfers to adjuvant radiation therapy in primary soft tissue sarcoma of the extremity","volume":"56","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib67-20230923","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/095530099140078","article-title":"Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer","volume":"75","year":"1999","journal-title":"Int J Radiat Biol"},{"key":"bib68-20230923","doi-asserted-by":"crossref","first-page":"20130439","DOI":"10.1259\/bjr.20130439","article-title":"Single institutional experience of the treatment of angiosarcoma of the face and scalp","volume":"86","year":"2013","journal-title":"Br J Radiol"},{"key":"bib69-20230923","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/bjd.13110","article-title":"Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study","volume":"171","year":"2014","journal-title":"Br J Dermatol"},{"key":"bib70-20230923","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1111\/j.1440-0960.2011.00746.x","article-title":"Cutaneous angiosarcoma of the leg showing radiation sensitivity","volume":"53","year":"2012","journal-title":"Australas J Dermatol"},{"key":"bib71-20230923","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0360-3016(01)02753-5","article-title":"Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome","volume":"52","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib72-20230923","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z","article-title":"Angiosarcoma. A report of 67 patients and a review of the literature","volume":"77","year":"1996","journal-title":"Cancer"},{"key":"bib73-20230923","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/COC.0b013e3182436ea3","article-title":"Radiation therapy for angiosarcoma: the 35-year university of Florida experience","volume":"36","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"bib74-20230923","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hed.20757","article-title":"Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement","volume":"30","year":"2008","journal-title":"Head Neck"},{"key":"bib75-20230923","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jso.23891","article-title":"Neoadjuvant chemotherapy for primary cutaneous\/soft tissue angiosarcoma: determining tumor behavior prior to surgical resection","volume":"111","year":"2015","journal-title":"J Surg Oncol"},{"key":"bib76-20230923","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jso.24352","article-title":"A prognostic model for resectable soft tissue and cutaneous angiosarcoma","volume":"114","year":"2016","journal-title":"J Surg Oncol"},{"key":"bib77-20230923","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijrobp.2008.06.1492","article-title":"Treatment of vascular soft tissue sarcomas with Razoxane, Vindesine, and radiation","volume":"74","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib78-20230923","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/030089160909500631","article-title":"Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma","volume":"95","year":"2009","journal-title":"Tumori"},{"key":"bib79-20230923","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cncr.22822","article-title":"Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients","volume":"110","year":"2007","journal-title":"Cancer"},{"key":"bib80-20230923","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.0.CO;2-P","article-title":"Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face","volume":"86","year":"1999","journal-title":"Cancer"},{"key":"bib81-20230923","article-title":"Confirmed activity and tolerability of weekly paclitaxel in the treatment of advanced angiosarcoma","volume":"2016","year":"2016","journal-title":"Sarcoma"},{"key":"bib82-20230923","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.ejca.2014.10.004","article-title":"First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma group trials","volume":"50","year":"2014","journal-title":"Eur J Cancer"},{"key":"bib83-20230923","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/annonc\/mdr066","article-title":"Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian rare cancer network","volume":"23","year":"2012","journal-title":"Ann Oncol"},{"key":"bib84-20230923","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","year":"2013","journal-title":"Ann Oncol"},{"key":"bib85-20230923","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/hed.20674","article-title":"Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies","volume":"30","year":"2008","journal-title":"Head Neck"},{"key":"bib86-20230923","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/0284186X.2016.1234068","article-title":"Pazopanib in advanced vascular sarcomas: an EORTC soft tissue and bone sarcoma group (STBSG) retrospective analysis","volume":"56","year":"2017","journal-title":"Acta Oncol"},{"key":"bib87-20230923","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/jamadermatol.2015.2554","article-title":"Growth attenuation of cutaneous angiosarcoma with propranolol-mediated \u03b2-blockade","volume":"151","year":"2015","journal-title":"JAMA Dermatology"},{"key":"bib88-20230923","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ebiom.2016.02.026","article-title":"Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: a bench to bedside study","volume":"6","year":"2016","journal-title":"EBioMedicine"},{"key":"bib89-20230923","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/bjd.16676","article-title":"Three patients with advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and chemokine (C-X-C motif) ligand 10 as possible biomarkers predicting the biological behaviour of angiosarcoma","volume":"179","year":"2018","journal-title":"Br J Dermatol"},{"key":"bib90-20230923","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/1346-8138.13775","article-title":"Case of angiosarcoma of the scalp successfully controlled by eribulin","volume":"45","year":"2018","journal-title":"J Dermatol"},{"key":"bib91-20230923","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/CAD.0000000000000558","article-title":"A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulin","volume":"29","year":"2018","journal-title":"Anti-Cancer Drugs"},{"key":"bib92-20230923","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ijrobp.2004.08.008","article-title":"Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy","volume":"61","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib93-20230923","first-page":"358","article-title":"Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: a case report and review of literature","volume":"25","year":"2013","journal-title":"Chin J Cancer Res"},{"key":"bib94-20230923","first-page":"697","article-title":"A case of retroperitoneal angiosarcoma effectively treated with recombinant interleukin-2","volume":"103","year":"2012","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"bib95-20230923","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2230.1993.tb02255.x","article-title":"A case of malignant haemangioendothelioma treated with recombinant interleukin-2","volume":"18","year":"1993","journal-title":"Clin Exp Dermatol"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000637-201907000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T01:02:05Z","timestamp":1695430925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000637-201907000-00011"}},"subtitle":["A Retrospective Analysis of 15 Patients"],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000001865","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}